EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TLR7-independent control of retroviral infection

Robert Z Zhang iD, Lia Robben iD, Ashley Willey, Sandra Umana, Vincent Mele, Brady Callahan iD, Tatyana Golovkina, Kevin R McCarthy iD, Melissa Kane iD

Proceedings of the National Academy of Sciences · 10.11.2026 · 123 (45)

DOI: 10.1073/pnas.2615151123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 02.11.2026. Verfasst von Robert Z Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15224. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Retroviridae Infections, Membrane Glycoproteins. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | National Cancer Institute (NCI), NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Development of effective immune responses against any pathogen requires efficient activation of the innate immune system followed by induction of an appropriate adaptive immune response using specific signaling pathways tailored to each infection. The sole innate immune receptor implicated in the induction of adaptive immunity to retroviral infection is Toll-like receptor 7 (TLR7). We have found that germinal center responses, neutralizing antibody production, and clearance of murine leukemia virus (MLV) infection in BALB.J and C57BL/6N (B6N) mice occurs in the absence of TLR7 signaling. This suggests that a previously unknown alternative sensing pathway exists for the activation of protective immune responses upon retroviral infection. Genetic crosses indicate that the ability to control retroviral infection in the absence of TLR7 signaling is determined by the same recessive mechanism in both B6N and BALB.J mice, suggesting that TLR7-independent responses do not result from a gain-of-function of an alternative pattern recognition receptor. Additionally, we observed that TLR7-deficient BALB.J mice produce neutralizing antibodies against mouse mammary tumor virus (MMTV) infection, indicating that this alternative sensing pathway is active against retroviruses of multiple genera. Finally, we determined that the alternative sensing pathway is also independent of both MyD88 and STING signaling. The ability of mice of two genetic backgrounds to control retroviral infection in the absence of TLR7 signaling provides a valuable tool for the identification of an additional mechanism of retrovirus control. The dissection of this pathway has the potential to alter our understanding of the requirements for the stimulation of antigen-specific neutralizing immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7Retroviridae InfectionsMembrane GlycoproteinsAnimalsMiceSignal TransductionMice, Inbred C57BLMice, Inbred BALB CImmunity, InnateLeukemia Virus, MurineAntibodies, NeutralizingMammary Tumor Virus, MouseFemaleMice, KnockoutGerminal Center

Stichwörter der Autor:innen

antiviral antibodiesinnate immunitymurine geneticsretrovirus

Substanzen

Toll-Like Receptor 7Tlr7 protein, mouseMembrane GlycoproteinsAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Infectious Diseases, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15224.
  • Department of Microbiology, University of Chicago, Chicago, IL 60637.
  • Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15219.

ORCID-Profile: Robert Z Zhang, Lia Robben, Brady Callahan, Kevin R McCarthy, Melissa Kane

Förderung

  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • HHS | NIH | National Cancer Institute (NCI)
  • NIGMS NIH HHS
  • NCI NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS
  • Diane and Cliff Rowe Research Fund

Zitieren

APA

Zhang, R. Z., Robben, L., Willey, A., Umana, S., Mele, V., Callahan, B., Golovkina, T., McCarthy, K. R., & Kane, M. (2026). TLR7-independent control of retroviral infection. Proceedings of the National Academy of Sciences, 123(45). https://doi.org/10.1073/pnas.2615151123

Vancouver

Zhang RZ, Robben L, Willey A, Umana S, Mele V, Callahan B, et al. TLR7-independent control of retroviral infection. Proceedings of the National Academy of Sciences. 2026;123(45). doi:10.1073/pnas.2615151123

BibTeX
@article{Zhang2026,
  author = {Zhang, Robert Z and Robben, Lia and Willey, Ashley and Umana, Sandra and Mele, Vincent and Callahan, Brady and Golovkina, Tatyana and McCarthy, Kevin R and Kane, Melissa},
  title = {TLR7-independent control of retroviral infection},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {45},
  doi = {10.1073/pnas.2615151123}
}
Kostenlos starten →